MARISA BUONANNO HAMRAH: Open Payments
NPI 1215104963 · WEST ORANGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 47 payments from 12 companies in 2025. Trend: 2023 $404 · 2024 $616 · 2025 $833
Food & beverage: $734Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $215 |
| AstraZeneca Pharmaceuticals LP | 9 | $152 |
| Sumitomo Pharma America, Inc. | 15 | $146 |
| Merck Sharp & Dohme LLC | 5 | $104 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| ABBVIE INC. | 2 | $34 |
| Caris MPI, Inc. | 1 | $24 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| Verastem, Inc. | 1 | $20 |
| Tempus AI, Inc | 1 | $20 |
Products named: LYNPARZA, MYFEMBREE, Veozah, KEYTRUDA, JEMPERLI, ELAHERE, MI CANCER SEEK, PRECISETUMOR.
Industry payments across NJ — which companies pay providers there.
